Daniel J. Becker, Director at Pandion Therapeutics, Inc. (PAND), bought 56,618 shares at $15.26 ($867K) on 2020-11-18, disclosed to the SEC on 2020-11-19.
Open-market purchase of $867k PAND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 2,170 | $32K | 3.7% |
| 2 | $15.43 | 13,027 | $201K | 23.2% |
| 3 | $15.43 | 13,027 | $201K | 23.2% |
| 4 | $15.26 | 14,197 | $217K | 25.0% |
| 5 | $15.26 | 14,197 | $217K | 25.0% |
| Total | $15.31 avg | 56,618 |
| $867K |
| 100% |
| Filing → |
| DAWN | BUY | 2021-06-01 | $80K | — | Filing → |
| PAND | BUY | 2020-11-23 | $6.0M | — | Filing → |
| PAND | BUY | 2020-07-21 | $13.0M | — | Filing → |